Skip to main content
. 2018 Sep 25;20(1):22–40. doi: 10.1111/obr.12757

Figure 1.

Figure 1

Identified tissue targets in the murine and human oxytocin system for treatment of metabolic dysfunction associated with the development of obesity and diabetes. Abbreviations: DIO, diet‐induced obesity; FABP4, fatty acid binding protein 4; NEFA, non‐esterified fatty acids; ob/ob, obese leptin‐deficient mouse model. [Colour figure can be viewed at wileyonlinelibrary.com]